It is not surprising that I cannot find any research articles on Cannabidiol and Lead Poisoning. However, if I were exposed to lead or if my child were exposed to lead, I would I would certainly take CBD.

Most of us know that the Federal Government patented CBD in October 2003 in large part, stating the Cannabidiol can prevent brain damage from a multitude of causes.

There is recent data that CBD can prevent neuro-toxicity from a chemotherapy agent called Taxol. I have seen many, many patients with severe neuropathic pain as a result of Taxol therapy for Breast Cancer.

The success rate in treating Taxol neuropathic pain is good. There are hundreds of animal studies showing CBD’s ability to prevent various forms of neurotoxicity.

CBD is an incredibly safe medicine. I know what I would do if I lived in Flint. Flint is in a Medical Cannabis state with access to CBD.

This should at least be on the table for discussion.

Allan Frankel, MD Dr Allan Frankel is one of the few physicians in the US who truly understands Cannabis as a medicine. All treatments suggested have been well studied. Every patient seen by Dr Frankel is given a personally created Treatment Plan created with the patient's specific issues defined. Plant medicine requires "tuning" of the dosing. Dr Frankel works with his patients thru a messaging portal. The use of this portal, allows quick and simple follow up contact with Dr Frankel. Patients are not charged for these messages, as this is how Dr Frankel has learned what he has learned. Follow up appointments in person or by phone/video are also available when needed

You Might Also Enjoy...

Rationing Health Care

With COVID, we have never been more aware of critical shortages of masks, ventilators, hospital beds, etc., all leading to rationing. In this BLOG, Dr Frankel, examines how rationing in our medical care is a much bigger problem than just face masks.

Cannabis May Prevent COVID-19 Infections

Early studies in both Israel and Canada show findings consistent with CBD's effect on COVID-19's ability to take hold in the lungs or the gastrointestinal tract. If the receptors are reduced, the viral infection and pulmonary toxicity should be reduced.